Clinical Trial Update: A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares triheptanoin with even-chain medium-chain triglycerides to assess metabolic crisis events in pediatric patients with long-chai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long-chain Fatty Acid Oxidation Disorders

Drugs mentioned

• Even-chain medium-chain triglycerides (even-chain medium-chain triglycerides)
• Triheptanoin (triheptanoin)

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) | Phase 3 | Status: ACTIVE_NOT_RECRUITING